Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
Cell Death Dis
.
2022 Apr 19;13(4):367.
doi: 10.1038/s41419-022-04743-7.
Authors
Violetta Ritter
1
,
Franziska Krautter
1
,
Diana Klein
1
,
Verena Jendrossek
1
,
Justine Rudner
2
Affiliations
1
Institute for Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
2
Institute for Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany. justine.rudner@uk-essen.de.
PMID:
35440079
PMCID:
PMC9018877
DOI:
10.1038/s41419-022-04743-7
No abstract available
Publication types
Published Erratum